21

22 “... made about the natural history of gMG and the anticipated use of eculizumab. Together, these introduce...”

23 “... but no history of stroke have a stroke risk of 4.5% per year; however, anticoagulation therapy, can reduce...”

24

25

26

27 “... but no history of stroke have a stroke risk of 4.5% per year; however, anticoagulation therapy, can reduce...”

28

29 “... and desirable option, given the known limitations of LS pre-selection criteria based on age, history...”

30

31 “... physical examination, patient history, and specialized tests (including urine succinylacetone levels...”

32 “... physical examination, patient history, and specialized tests (including urine succinylacetone levels...”

33 “... and desirable option, given the known limitations of LS pre-selection criteria based on age, history...”

34

35

36

37

38

39

40